XX.YY.2012/1 Cooperative European Medicines Development Course (CEMDC) Sándor Kerpel-Fronius, M.D., D.Sc. Semmelweis University Department of Pharmacology and Pharmacotherapy Budapest, Hungary Email: [email protected]WP5 Geographical Extension Project
5
Embed
Cooperative European Medicines Development Course (CEMDC)
WP5 Geographical Extension Project. Cooperative European Medicines Development Course (CEMDC). Sándor Kerpel-Fronius , M.D., D.Sc. Semmelweis University Department of Pharmacology and Pharmacotherapy Budapest, Hungary Email: [email protected]. Czech Republic , Prague ? - PowerPoint PPT Presentation
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
XX.YY.2012/1
Cooperative European Medicines Development Course (CEMDC)
Sándor Kerpel-Fronius, M.D., D.Sc.Semmelweis UniversityDepartment of Pharmacology and PharmacotherapyBudapest, HungaryEmail: [email protected]
Supervision of administration.Delivery of the educatinal
program
PharmaTrainHarmonised educational program
Quality Assurance
International Advisory Board
GOVERNING BOARDCoordinating University
Study Director Quality Assurance
Educationa CommitteeModule Leaders
Study Management Group
XX.YY.2012/4
Joint student group
Joint educational staff
Organization of joint education
All the teaching activities will be done jointly for all the enrolled students by a joint educational staff
XX.YY.2012/5
IMI-Pharmatrain course structure
Base course (6 base modules, 30 ECTS)
1. Introduction. Drug discovery2. Non-clinical drug development3. Early clinical drug development4. Confirmatory clinical drug trials5. Drug regulation and
pharmacovigilance6. Healthcare, marketplace,
economics of healthcare
Six additional modules, 30 ECTSExtension modules1. Pharmacoeconomics , drug reimbursement2. Drug safety, pharmaco- epidemiology, pharmacovigilance, risk management 3. Biological medicinal products and advanced therapies4. Specific patient populations Eligible modules5. Generic and biosimilar medicinal agents6. Development of medicinal devices